The StemCellFactory: A Modular System Integration for Automated Generation and Expansion of Human Induced Pluripotent Stem Cells.

automation cell culture cell production induced pluripotent stem cells reprogramming

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2020
Historique:
received: 05 07 2020
accepted: 09 09 2020
entrez: 26 11 2020
pubmed: 27 11 2020
medline: 27 11 2020
Statut: epublish

Résumé

While human induced pluripotent stem cells (hiPSCs) provide novel prospects for disease-modeling, the high phenotypic variability seen across different lines demands usage of large hiPSC cohorts to decipher the impact of individual genetic variants. Thus, a much higher grade of parallelization, and throughput in the production of hiPSCs is needed, which can only be achieved by implementing automated solutions for cell reprogramming, and hiPSC expansion. Here, we describe the StemCellFactory, an automated, modular platform covering the entire process of hiPSC production, ranging from adult human fibroblast expansion, Sendai virus-based reprogramming to automated isolation, and parallel expansion of hiPSC clones. We have developed a feeder-free, Sendai virus-mediated reprogramming protocol suitable for cell culture processing via a robotic liquid handling unit that delivers footprint-free hiPSCs within 3 weeks with state-of-the-art efficiencies. Evolving hiPSC colonies are automatically detected, harvested, and clonally propagated in 24-well plates. In order to ensure high fidelity performance, we have implemented a high-speed microscope for in-process quality control, and image-based confluence measurements for automated dilution ratio calculation. This confluence-based splitting approach enables parallel, and individual expansion of hiPSCs in 24-well plates or scale-up in 6-well plates across at least 10 passages. Automatically expanded hiPSCs exhibit normal growth characteristics, and show sustained expression of the pluripotency associated stem cell marker TRA-1-60 over at least 5 weeks (10 passages). Our set-up enables automated, user-independent expansion of hiPSCs under fully defined conditions, and could be exploited to generate a large number of hiPSC lines for disease modeling, and drug screening at industrial scale, and quality.

Identifiants

pubmed: 33240865
doi: 10.3389/fbioe.2020.580352
pmc: PMC7680974
doi:

Types de publication

Journal Article

Langues

eng

Pagination

580352

Informations de copyright

Copyright © 2020 Elanzew, Nießing, Langendoerfer, Rippel, Piotrowski, Schenk, Kulik, Peitz, Breitkreuz, Jung, Wanek, Stappert, Schmitt, Haupt, Zenke, König and Brüstle.

Références

Nat Methods. 2015 Sep;12(9):885-92
pubmed: 26237226
Nature. 2017 Jun 15;546(7658):370-375
pubmed: 28489815
Stem Cells. 2012 Mar;30(3):435-40
pubmed: 22162363
Biomaterials. 2010 Dec;31(34):9135-44
pubmed: 20817292
Nat Commun. 2012;3:1236
pubmed: 23212365
Nat Methods. 2006 Aug;3(8):637-46
pubmed: 16862139
Nat Commun. 2014;5:3195
pubmed: 24463987
Sci Rep. 2015 Mar 10;5:8973
pubmed: 25754700
Cell Stem Cell. 2017 Apr 6;20(4):518-532.e9
pubmed: 28017796
Sci Rep. 2015 Nov 17;5:16647
pubmed: 26573336
Cell Stem Cell. 2010 Nov 5;7(5):618-30
pubmed: 20888316
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Stem Cell Res. 2016 Sep;17(2):379-390
pubmed: 27639108
Nature. 2017 May 11;545(7653):229-233
pubmed: 28445466
Cell Stem Cell. 2012 May 4;10(5):570-82
pubmed: 22542160
SLAS Technol. 2018 Aug;23(4):315-325
pubmed: 28574793
Sci Rep. 2018 Nov 21;8(1):17201
pubmed: 30464253
EMBO J. 2019 Jun 17;38(12):
pubmed: 31088843
Cell Cycle. 2016;15(7):986-97
pubmed: 26919644
SLAS Discov. 2017 Sep;22(8):1016-1025
pubmed: 28287872
Nature. 2012 Nov 22;491(7425):603-7
pubmed: 23075850
Bioprocess Biosyst Eng. 2016 Dec;39(12):1847-1858
pubmed: 27503483
Cell Stem Cell. 2013 Aug 1;13(2):149-59
pubmed: 23910082
Nat Methods. 2011 May;8(5):424-9
pubmed: 21478862
Nat Biotechnol. 2015 Jan;33(1):58-63
pubmed: 25437882
Cell. 2019 Mar 21;177(1):162-183
pubmed: 30901538
Dis Model Mech. 2020 Jan 17;13(1):
pubmed: 31953356
Trends Genet. 2020 Mar;36(3):152-159
pubmed: 31932096
Mol Psychiatry. 2016 Sep;21(9):1167-79
pubmed: 27240529
Cell Rep. 2018 Jul 24;24(4):883-894
pubmed: 30044985
Nat Commun. 2017 Dec 20;8(1):2225
pubmed: 29263384
PLoS One. 2013 May 29;8(5):e65324
pubmed: 23734247
J Vis Exp. 2015 May 14;(99):e52755
pubmed: 26068617
J Biomed Sci. 2019 Oct 28;26(1):87
pubmed: 31660969
Biotechnol Lett. 2019 Nov;41(11):1245-1253
pubmed: 31541330
Stem Cell Reports. 2017 Jun 6;8(6):1784-1796
pubmed: 28591656
Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(8):348-62
pubmed: 19838014

Auteurs

Andreas Elanzew (A)

Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty and University Hospital Bonn, Bonn, Germany.
LIFE&BRAIN GmbH, Cellomics Unit, Bonn, Germany.

Bastian Nießing (B)

Fraunhofer Institute for Production Technology, Aachen, Germany.

Daniel Langendoerfer (D)

LIFE&BRAIN GmbH, Cellomics Unit, Bonn, Germany.

Oliver Rippel (O)

LIFE&BRAIN GmbH, Cellomics Unit, Bonn, Germany.
Fraunhofer Institute for Production Technology, Aachen, Germany.

Tobias Piotrowski (T)

Fraunhofer Institute for Production Technology, Aachen, Germany.

Friedrich Schenk (F)

Fraunhofer Institute for Production Technology, Aachen, Germany.

Michael Kulik (M)

Fraunhofer Institute for Production Technology, Aachen, Germany.

Michael Peitz (M)

Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty and University Hospital Bonn, Bonn, Germany.
Cell Programming Core Facility, University of Bonn Medical Faculty, Bonn, Germany.

Yannik Breitkreuz (Y)

Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty and University Hospital Bonn, Bonn, Germany.
LIFE&BRAIN GmbH, Cellomics Unit, Bonn, Germany.

Sven Jung (S)

Fraunhofer Institute for Production Technology, Aachen, Germany.

Paul Wanek (P)

Institute for Biomedical Engineering, Cell Biology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.

Laura Stappert (L)

LIFE&BRAIN GmbH, Cellomics Unit, Bonn, Germany.

Robert H Schmitt (RH)

Fraunhofer Institute for Production Technology, Aachen, Germany.
Laboratory for Machine Tools and Production, RWTH Aachen University, Aachen, Germany.

Simone Haupt (S)

Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty and University Hospital Bonn, Bonn, Germany.
LIFE&BRAIN GmbH, Cellomics Unit, Bonn, Germany.

Martin Zenke (M)

Institute for Biomedical Engineering, Cell Biology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.

Niels König (N)

Fraunhofer Institute for Production Technology, Aachen, Germany.

Oliver Brüstle (O)

Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty and University Hospital Bonn, Bonn, Germany.
LIFE&BRAIN GmbH, Cellomics Unit, Bonn, Germany.

Classifications MeSH